Thymic carcinoma: A multivariate analysis of factors predictive of survival in 290 patients

Benny Weksler, Rajeev Dhupar, Vishal Parikh, Katie S. Nason, Arjun Pennathur, Peter F. Ferson

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Background: Thymic carcinoma is a rare, aggressive disease with low 5-year survivals. We undertook this study to identify factors that impact prognosis and to better define the relationship between survival and surgical intervention. Methods: We queried the Surveillance, Epidemiology, and End Results cancer database and identified patients with thymic carcinoma. We performed univariate and multivariate analyses to identify factors prognostic for survival, focusing on demographic, tumor, and treatment variables. Results: For 290 patients with thymic carcinoma, the median survival was 48 months with 5-year survival of 30%. In multivariate analysis, type of surgical therapy (none, incomplete excision, complete thymic excision, debulking), Masaoka stage, and sex were important determinants of survival. Patients who underwent complete thymic excision had a significantly longer median survival than those who did not receive surgical therapy (105 versus 29 months; p < 0.001). In patients who underwent complete thymic excision, Masaoka stage and race were important determinants of survival in multivariate analysis. Conclusions: Complete thymic excision is the preferred primary treatment for thymic carcinoma. Masaoka stage has significant prognostic implications for all patients, including those who undergo complete thymic excision.

Original languageEnglish (US)
Pages (from-to)299-303
Number of pages5
JournalAnnals of Thoracic Surgery
Volume95
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Thymoma
Multivariate Analysis
Survival
Therapeutics
Rare Diseases
Neoplasms
Epidemiology
Demography
Databases

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Thymic carcinoma : A multivariate analysis of factors predictive of survival in 290 patients. / Weksler, Benny; Dhupar, Rajeev; Parikh, Vishal; Nason, Katie S.; Pennathur, Arjun; Ferson, Peter F.

In: Annals of Thoracic Surgery, Vol. 95, No. 1, 01.01.2013, p. 299-303.

Research output: Contribution to journalArticle

Weksler, Benny ; Dhupar, Rajeev ; Parikh, Vishal ; Nason, Katie S. ; Pennathur, Arjun ; Ferson, Peter F. / Thymic carcinoma : A multivariate analysis of factors predictive of survival in 290 patients. In: Annals of Thoracic Surgery. 2013 ; Vol. 95, No. 1. pp. 299-303.
@article{8f039fd0a87c4e9799443b1dbd0a35d6,
title = "Thymic carcinoma: A multivariate analysis of factors predictive of survival in 290 patients",
abstract = "Background: Thymic carcinoma is a rare, aggressive disease with low 5-year survivals. We undertook this study to identify factors that impact prognosis and to better define the relationship between survival and surgical intervention. Methods: We queried the Surveillance, Epidemiology, and End Results cancer database and identified patients with thymic carcinoma. We performed univariate and multivariate analyses to identify factors prognostic for survival, focusing on demographic, tumor, and treatment variables. Results: For 290 patients with thymic carcinoma, the median survival was 48 months with 5-year survival of 30{\%}. In multivariate analysis, type of surgical therapy (none, incomplete excision, complete thymic excision, debulking), Masaoka stage, and sex were important determinants of survival. Patients who underwent complete thymic excision had a significantly longer median survival than those who did not receive surgical therapy (105 versus 29 months; p < 0.001). In patients who underwent complete thymic excision, Masaoka stage and race were important determinants of survival in multivariate analysis. Conclusions: Complete thymic excision is the preferred primary treatment for thymic carcinoma. Masaoka stage has significant prognostic implications for all patients, including those who undergo complete thymic excision.",
author = "Benny Weksler and Rajeev Dhupar and Vishal Parikh and Nason, {Katie S.} and Arjun Pennathur and Ferson, {Peter F.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.athoracsur.2012.09.006",
language = "English (US)",
volume = "95",
pages = "299--303",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Thymic carcinoma

T2 - A multivariate analysis of factors predictive of survival in 290 patients

AU - Weksler, Benny

AU - Dhupar, Rajeev

AU - Parikh, Vishal

AU - Nason, Katie S.

AU - Pennathur, Arjun

AU - Ferson, Peter F.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background: Thymic carcinoma is a rare, aggressive disease with low 5-year survivals. We undertook this study to identify factors that impact prognosis and to better define the relationship between survival and surgical intervention. Methods: We queried the Surveillance, Epidemiology, and End Results cancer database and identified patients with thymic carcinoma. We performed univariate and multivariate analyses to identify factors prognostic for survival, focusing on demographic, tumor, and treatment variables. Results: For 290 patients with thymic carcinoma, the median survival was 48 months with 5-year survival of 30%. In multivariate analysis, type of surgical therapy (none, incomplete excision, complete thymic excision, debulking), Masaoka stage, and sex were important determinants of survival. Patients who underwent complete thymic excision had a significantly longer median survival than those who did not receive surgical therapy (105 versus 29 months; p < 0.001). In patients who underwent complete thymic excision, Masaoka stage and race were important determinants of survival in multivariate analysis. Conclusions: Complete thymic excision is the preferred primary treatment for thymic carcinoma. Masaoka stage has significant prognostic implications for all patients, including those who undergo complete thymic excision.

AB - Background: Thymic carcinoma is a rare, aggressive disease with low 5-year survivals. We undertook this study to identify factors that impact prognosis and to better define the relationship between survival and surgical intervention. Methods: We queried the Surveillance, Epidemiology, and End Results cancer database and identified patients with thymic carcinoma. We performed univariate and multivariate analyses to identify factors prognostic for survival, focusing on demographic, tumor, and treatment variables. Results: For 290 patients with thymic carcinoma, the median survival was 48 months with 5-year survival of 30%. In multivariate analysis, type of surgical therapy (none, incomplete excision, complete thymic excision, debulking), Masaoka stage, and sex were important determinants of survival. Patients who underwent complete thymic excision had a significantly longer median survival than those who did not receive surgical therapy (105 versus 29 months; p < 0.001). In patients who underwent complete thymic excision, Masaoka stage and race were important determinants of survival in multivariate analysis. Conclusions: Complete thymic excision is the preferred primary treatment for thymic carcinoma. Masaoka stage has significant prognostic implications for all patients, including those who undergo complete thymic excision.

UR - http://www.scopus.com/inward/record.url?scp=84871878128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871878128&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2012.09.006

DO - 10.1016/j.athoracsur.2012.09.006

M3 - Article

C2 - 23141529

AN - SCOPUS:84871878128

VL - 95

SP - 299

EP - 303

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

ER -